Royal Wound-X Launches Two New Wound Healing Technologies

Royal Wound-X, a division of Royal Biologics, has launched two cutting-edge for wound care, the Peak Powder Collagen Matrix and the ElectroFiber 3D. 
 
Salvatore Leo, CEO and founder of Royal Biologics, remarked, “Peak Powder and ElectroFiber 3D represent new and innovative technologies we are launching to expand our portfolio in wound care. These unique technologies combine natural healing properties with cutting-edge science to provide a faster, more effective healing solution for patients.”
 
Peak Powder Collagen Matrix is a next-generation collagen-based wound care solution designed to enhance healing in both surgical and non-surgical wounds. 
 
Composed of 100% bovine Type 1 collagen, Peak Powder optimizes the wound environment, supports tissue regeneration, and significantly speeds up healing. The Collagen Matrix forms a gel-like barrier that creates an optimal moist, low-pH environment for tissue regeneration, promoting critical biological processes such as granulation tissue formation and epithelialization.
 
Peak Powder also helps regulate enzymes like Matrix Metalloproteinase (MMP), enhancing fibroblast proliferation and angiogenesis. With broad-spectrum antimicrobial protection, Peak Powder combats common hospital-acquired pathogens such as S. aureus, E. coli, and C. albicans, reducing the risk of infection.
 
The Peak Power Collagen Matrix can be used in Orthopedics, Podiatry, Spine, Plastic Surgery, and General Surgery. It is also highly effective in treating burns and ulcers. 
 
In-vitro testing has shown that Peak Powder can reduce wound healing time by up to 50% while absorbing up to 30 times its weight in wound exudate, offering significant benefits for patients and healthcare providers.
 
ElectroFiber 3D is a bioengineered, electrospun synthetic polymer matrix designed to accelerate wound healing. It is an FDA 510(k) approved medical device and is indicated for use in partial and full-thickness wounds, as well as burns.
 
It consists of resorbable polymers such as polyglycolic acid (PGA) and poly lactide co-caprolactone (PLCL). ElectroFiber 3D provides a microporous scaffold that supports cellular migration and proliferation. It also helps reduce the wound pH from 7.4 to 5.9 within 78 hours, and further to 4.0 within two weeks, creating an ideal environment for tissue regeneration and infection control.
 
The product offers rapid wound closure, with clinical studies showing a reduction in healing time to under eight weeks with only two or fewer applications required.
 
The company will also showcase these technologies at the 2024 Symposium on Advanced Wound Care (SAWC) Fall Conference in Las Vegas, Nevada.